164 related articles for article (PubMed ID: 37620558)
21. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):903-911. PubMed ID: 35999514
[TBL] [Abstract][Full Text] [Related]
22. Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma.
Liu PH; Hsia CY; Lee YH; Hsu CY; Huang YH; Su CW; Lee RC; Lin HC; Huo TI
J Surg Oncol; 2015 Mar; 111(4):404-9. PubMed ID: 25643842
[TBL] [Abstract][Full Text] [Related]
23. Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
Liu PH; Lee YH; Hsia CY; Hsu CY; Huang YH; Chiou YY; Lin HC; Huo TI
Ann Surg Oncol; 2014 Jun; 21(6):1825-33. PubMed ID: 24499831
[TBL] [Abstract][Full Text] [Related]
24. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?
Kim JM; Kwon CH; Joh JW; Kim SJ; Shin M; Kim EY; Moon JI; Jung GO; Choi GS; Lee SK
Transplant Proc; 2010 Apr; 42(3):821-4. PubMed ID: 20430181
[TBL] [Abstract][Full Text] [Related]
25. Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases.
Izumoto H; Hiraoka A; Ishimaru Y; Murakami T; Kitahata S; Ueki H; Aibiki T; Okudaira T; Miyamoto Y; Yamago H; Iwasaki R; Tomida H; Mori K; Kishida M; Tsubouchi E; Miyata H; Ninomiya T; Kawasaki H; Hirooka M; Matsuura B; Abe M; Hiasa Y; Michitaka K; Kudo M
Oncology; 2017; 93 Suppl 1():120-126. PubMed ID: 29258105
[TBL] [Abstract][Full Text] [Related]
26. Clinical prognosis of surgical resection versus transarterial chemoembolization for single large hepatocellular carcinoma (≥5 cm): A propensity score matching analysis.
Hsieh PM; Hsiao P; Chen YS; Yeh JH; Hung CM; Lin HY; Ma CH; Tang T; Huang YW; Cheng PN; Hsieh KC; Hu KC; Bair MJ; Lin CW
Kaohsiung J Med Sci; 2023 Mar; 39(3):302-310. PubMed ID: 36625289
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hepatocellular carcinoma beyond the Milan criteria. A weighted comparative study of surgical resection versus chemoembolization.
Famularo S; Di Sandro S; Giani A; Bernasconi DP; Lauterio A; Ciulli C; Rampoldi AG; Corso R; De Carlis R; Romano F; Braga M; Gianotti L; De Carlis L
HPB (Oxford); 2020 Sep; 22(9):1349-1358. PubMed ID: 31932243
[TBL] [Abstract][Full Text] [Related]
28. An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Su CW; Huang YH; Lei HJ; He YJ; Hou MC; Huo TI
Am J Clin Oncol; 2019 Sep; 42(9):698-704. PubMed ID: 31335351
[TBL] [Abstract][Full Text] [Related]
29. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
30. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
31. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
[TBL] [Abstract][Full Text] [Related]
32. Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria.
Huang CT; Chu YL; Su TH; Huang SC; Tseng TC; Hsu SJ; Liao SH; Hong CM; Liu CH; Yang HC; Liu CJ; Chen PJ; Kao JH
Liver Cancer; 2023 Dec; 12(6):539-549. PubMed ID: 38476293
[TBL] [Abstract][Full Text] [Related]
33. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
34. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma within Milan criteria: A propensity score matching analysis.
Guo Z; Zhong Y; Hu B; Jiang JH; Li LQ; Xiang BD
Medicine (Baltimore); 2017 Dec; 96(51):e8933. PubMed ID: 29390426
[TBL] [Abstract][Full Text] [Related]
35. Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis.
Shen L; Chen S; Qiu Z; Qi H; Yuan H; Cao F; Xie L; Chen Q; Li W; Fan W
J Cancer Res Ther; 2020 Sep; 16(5):1063-1068. PubMed ID: 33004748
[TBL] [Abstract][Full Text] [Related]
36. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
Liu S; Li H; Guo L; Zhang B; Zhou B; Zhang W; Zhou J; Fan J; Ye Q
Oncologist; 2019 Apr; 24(4):513-520. PubMed ID: 30552155
[TBL] [Abstract][Full Text] [Related]
37. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
World J Surg; 2018 Jun; 42(6):1841-1847. PubMed ID: 29138913
[TBL] [Abstract][Full Text] [Related]
38. Preoperative transarterial chemoembolization for barcelona clinic liver cancer stage A/B hepatocellular carcinoma beyond the milan criteria: a propensity score matching analysis.
Guo C; Zou X; Hong Z; Sun J; Xiao W; Sun K; Li X; Shen Y; Liang T; Bai X
HPB (Oxford); 2021 Sep; 23(9):1427-1438. PubMed ID: 33715958
[TBL] [Abstract][Full Text] [Related]
39. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.
Kim SS; Cho HJ; Won JH; Bae JI; Kang DR; Lee JD; Shin SJ; Lee KM; Yoo BM; Kim JK; Lee JH; Ahn SJ; Park JH; Cho SW; Cheong JY
Cytokine; 2015 Dec; 76(2):449-457. PubMed ID: 26163999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]